In patients with resected non-small cell lung cancer, a combined immunohistochemistry score of calmodulin, thymosin beta‑4 and thymosin beta-10 correlated with patient survival.
In plain wordsIn people with resected lung cancer, a combined tissue score of three proteins, including the body's own thymosin beta‑4, was linked to survival.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- Not applicableSurvival correlation of combined IHC score (calmodulin, thymosin beta-4, thymosin beta-10)
- Study
n: not reported in source
- Outcome group
- Mortality · Cancer
Source sentences
The combined IHC scores of calmodulin, thymosin beta-4, and thymosin beta-10 were found to be correlated with NSCLC patient survival (p = 0.004).
1 context sentence(design, population, supporting numbers)
Protein signals obtained directly from frozen lung tissue sections using MALDI-MS were used to predict nodal involvement and survival in resected non-small cell lung cancer (NSCLC).
In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).